Dry Mouth Relief Market Research, 2033
The global dry mouth relief market size was valued at $2.5 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033. The dry mouth relief market primarily driven by the rise in prevalence of oral diseaes, increased usage of medications that cause dry mouth as a side effect, and a growing awareness about oral health.
Market Introduction and Definition
Dry mouth relief refers to strategies, treatments, or products designed to alleviate the discomfort and symptoms associated with dry mouth, also known as xerostomia. This condition occurs when the salivary glands produce insufficient saliva, leading to a dry, sticky feeling in the mouth, difficulty speaking or swallowing, and potential oral health issues. Relief measures may include using saliva substitutes, staying hydrated, practicing good oral hygiene, and using medications or sprays specifically formulated to stimulate saliva production. Effective dry mouth relief aims to restore moisture, improve oral comfort, and prevent complications such as tooth decay and gum disease.
Key Takeaways
- The dry mouth relief market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major dry mouth relief industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The dry mouth relief market growth, driven by rise in prevalence of dry mouth, or xerostomia, which is often a side effect of various medications, medical conditions like diabetes, and aging. This growing incidence is creating a larger patient base in need of specialized relief products. In addition, the aging population is a significant factor, as older adults frequently experience dry mouth due to medications and natural reductions in saliva production. This demographic shift drives the dry mouth relief market growth.
Furthermore, increase in awareness and education about dry mouth and its treatments have also played a crucial role, leading to higher diagnosis rates and more patients seeking effective relief, thereby supporting the growth during dry mouth relief market forecast period. Moreover, the growing acceptance of over-the-counter solutions and the convenience of purchasing these products from retail pharmacies and online platforms contribute to the market’s expansion. Prescription-based treatments also support market growth by providing targeted relief for severe cases of dry mouth, addressing conditions that over-the-counter products might not effectively manage. The emergence of new and advanced treatment options, coupled with the expanding availability of these products across various distribution channels, ensures that patients have access to effective solutions tailored to their needs.
However, limited awareness and understanding of dry mouth and its treatments may lead to underdiagnosis and lower product adoption, thereby restricting the market growth. In addition, potential side effects of some relief products may limit the use of these treatments. Regulatory hurdles and lengthy approval processes for new treatments can also delay market innovation and product availability.
On other hand, innovative formulations and delivery methods have enhanced the efficacy and appeal of dry mouth relief products, which provides an dry mouth relief market opportunity. For instance, new mouthwashes, sprays, and gels specifically designed to address dry mouth symptoms offer improved hydration and comforts.
Patent Analysis for Dry Mouth Reliefs, By Country (2015-2024)
According to the World Intellectual Property Organization (WIPO) , patent analysis for dry mouth relief from 2015 to 2024 reveals significant innovation activity across various countries, reflecting a dynamic and evolving market. China leads with 27.8% of patents, highlighting its strong focus on developing new technologies and solutions for dry mouth relief. The U.S. follows closely with 20.4%, indicating a robust market driven by substantial R&D investments and technological advancements. The Patent Cooperation Treaty (PCT) accounts for 14.8%, demonstrating the global nature of innovation and cross-border collaborations. Australia and Canada each contribute 13.0% and 5.6%, respectively, showing their growing engagement in addressing dry mouth issues. The European Patent Office also holds 5.6%, reflecting the region's commitment to advancing oral health technologies. The remaining 13.0% of patents are distributed across other regions, suggesting a widespread, albeit smaller-scale, global interest. This patent distribution emphasizes a competitive and innovative dry mouth relief market, with key players worldwide contributing to the development of effective solutions and driving market growth through continuous advancements.
Market Segmentation
The dry mouth relief market size is segmented into product type, type, sales channel, and region. On the basis of product type, the market is segmented into spray, mouthwash, gel, lozenges, and others. By type, the market is classified into over-the-counter (OTC) and prescribed. By sales channel, the market is divided into online and offline. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
The North America dry mouth relief market share is supported by high awareness, advanced healthcare infrastructure, and significant patient base. In addition, strong distribution networks, including widespread retail and online availability, facilitate easy access to relief solutions and further supports the market growth in this region. Ongoing research and development in product formulations also supports market expansion by offering innovative and effective treatments. Europe also maintains a strong market presence, supported by comprehensive healthcare systems and rising consumer demand for effective relief products. The Asia-Pacific region is witnessing rapid growth driven by increasing healthcare access, a growing elderly population, and heightened awareness of dry mouth conditions. LAMEA is an emerging market with expanding healthcare infrastructure and increasing patient awareness contributing to the market growth.
Industry Trends
- In 2023, the National Institute of Dental and Craniofacial Research (NIDCR) had actively investigated therapies to repair damaged salivary glands and restore saliva flow. Their studies focus on genetic and molecular causes of salivary dysfunction, which can arise from various conditions, including autoimmune diseases and cancer treatments. Globally, about 1 in 5 people experience dry mouth due to a breakdown in saliva production. This highlights the urgent need for effective solutions but also drives the market growth by fostering new developments and encouraging investment in advanced therapeutic options.
- In March 2024, Haleon, a leading consumer health company, celebrated World Oral Health Day 2024 by announcing significant progress in reducing the environmental impact of its toothpaste products and promoting oral health inclusivity globally. Haleon has also partnered with the FDI World Dental Federation (FDI) to support its World Oral Health Day campaign for the second consecutive year. This initiative is likely to drive the dry mouth relief market by increasing awareness about oral health and the importance of managing oral conditions.
Competitive Landscape
The major players operating in the market include SUNSTAR Suisse S.A., Sanofi, bioXtra, A. S. Pharma, Colgate-Palmolive, 3M, Fresenius Kabi, Oralieve, Haleon, and Parnell Pharmaceuticals Inc.
Recent Key Strategies and Developments in Dry Mouth Relief Industry
- In May 2023, Rapid Dose Therapeutics Corp., a Canadian biotechnology company revolutionizing drug delivery through innovation, launched two unique dental QuickStrip products across the country. XyliStrip is an oral dissolving thin film strip to be used for the treatment of dry mouth and xerostomia.
Key Sources Referred
- National Center for Biotechnology and Information (NCBI)
- Centers for Medicare & Medicaid Services (CMS)
- Government of Canada's Health and Wellness
- Ministry of Health and Family Welfare (MoHFW)
- National Health Mission (NHM)
- Centers for Disease Control and Prevention (CDC)
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- European Medicines Agency (EMA)
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dry mouth relief market analysis from 2024 to 2033 to identify the prevailing dry mouth relief market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the dry mouth relief market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global dry mouth relief market trends, key players, market segments, application areas, and market growth strategies.
Dry Mouth Relief Market , by Product Type Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 4.6 Billion |
 Growth Rate | CAGR of 6.1% |
 Forecast period | 2024 - 2033 |
 Report Pages | 240 |
 By Product Type |
|
 By Type |
|
 By Sales Channel |
|
 By Region |
|
 Key Market Players | bioXtra , Fresenius Kabi , Sanofi, Oralieve, Colgate-Palmolive, 3M, A. S. Pharma, SUNSTAR Suisse S.A., Parnell Pharmaceuticals Inc., Haleon |
The total market value of dry mouth relief market was $2.5 billion in 2023.
The market value of dry mouth relief market is projected to reach $4.6 billion by 2033.
The forecast period for dry mouth relief market is 2024 to 2033.
The base year is 2023 in dry mouth relief market.
The dry mouth relief market includes products like oral sprays, lozenges, gels, and rinses designed to alleviate symptoms of xerostomia (dry mouth), often caused by medication, aging, or medical conditions such as diabetes and Sjögren's syndrome.
The market is driven by an increasing number of people suffering from medication-induced dry mouth, a growing elderly population, and heightened awareness rega6rding oral health.
Loading Table Of Content...
